Inspirational Research — Our Customers Share Their Stories​

Indivumed Therapeutics

Malik Kenka, Senior Director of IHC Development, and Daniel Bilius, Senior Scientist, share their experience in leading teams that develop IHC assays on automated staining platforms for biotech and pharma customers. They focus on implementing the latest Multiplex IHC technologies to meet customer needs in pre-clinical and clinical programs. The BOND RX research stainer from Leica Biosystems was chosen for its ability to perform automated fluorescence Multiplex IHC, chromogenic IHC, and RNA scope, ensuring high sensitivity, reproducibility, and flexibility in protocol development.

The platform's intuitive design simplifies training, while its flexibility allows for the testing of various staining conditions and reagents. The team believes that Multiplex IHC will play a significant role in future diagnostics and patient stratification for therapies, urging colleagues to adopt and master this technology for its potential in providing valuable data for routine diagnostics. 

View More Customer Stories here: Customer Testimonials - YouTube

Learn more about Indivumed.